Holen Sie sich die Stockscreener-App
927.06
0.91%
-8.52
Handel nachbörslich:
926.20
-0.86
-0.09%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
Eli Lilly and Company (NYSE:LLY) Stock Price Down 1% on Analyst Downgrade - marketbeat.com
Eli Lilly and Co.’s Foundayo: New FDA-approved oral weight loss medication - WISH-TV
FDA Approves Eli Lilly GLP-1 Pill for Weight Loss - Mix93.3
Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime - Investing.com
New GLP-1 drug will be made in Houston - KHOU
How to Play Lilly Stock Post Oral Obesity Pill Foundayo's Approval - Yahoo Finance
Novo Nordisk says its Wegovy pill beats Eli Lilly's rival on weight loss - qz.com
Lilly vs JPMorgan: Which Hits a $1 Trillion Market Cap First? - 247wallst.com
Eli Lilly’s Path to $1 Trillion Runs Directly Through the AI Boom - AOL.com
Eli Lilly takes the court with 150th anniversary campaign to catch Final Four crowd - fiercepharma.com
Eli Lilly & Co. stock: Foundayo approval drives gains – what it means for you - AD HOC NEWS
Eli Lilly's $6.5B Houston plant will make its new FDA-approved GLP-1 weight loss drug - The Business Journals
Evexia Wealth LLC Sells 1,147 Shares of Eli Lilly and Company $LLY - marketbeat.com
Eli Lilly and Company $LLY is Aberdeen Group plc's 10th Largest Position - marketbeat.com
Eli Lilly and Company (NYSE:LLY) Stock Rating Lowered by Wall Street Zen - marketbeat.com
Eli Lilly's Foundayo Launch and Strategic Acquisition Signal Aggressive Growth - AD HOC NEWS
StockWatch: Price War Dampens Lilly Surge After Oral GLP-1 Wins FDA Nod - Genetic Engineering and Biotechnology News
Oral Weight-Loss Drug Battle: Novo Nordisk vs Eli Lilly's New TreatmentsNews and Statistics - indexbox.io
AI Models Split on Eli Lilly (LLY) as Growth Strength Meets Premium Valuation - TipRanks
HF Advisory Group LLC Boosts Stake in Eli Lilly and Company $LLY - marketbeat.com
SWS Partners Makes New $2.39 Million Investment in Eli Lilly and Company $LLY - MarketBeat
Herbst Group LLC Makes New Investment in Eli Lilly and Company $LLY - marketbeat.com
Banque Pictet & Cie SA Cuts Holdings in Eli Lilly and Company $LLY - marketbeat.com
Beacon Investment Advisory Services Inc. Sells 1,080 Shares of Eli Lilly and Company $LLY - marketbeat.com
Jim Cramer Believes Eli Lilly’s “Weight Loss Pill Will Be a Blockbuster” - Insider Monkey
Eli Lilly (LLY) Is Up 6.5% After FDA Clears Anytime Oral GLP-1 Foundayo for Obesity Treatment - simplywall.st
Jim Cramer Likes Eli Lilly’s (LLY) New Deal - Insider Monkey
Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight - The Motley Fool
Eli Lilly and Company $LLY Shares Sold by Weatherly Asset Management L. P. - marketbeat.com
Frank Rimerman Advisors Boosts Eli Lilly Stock Position - National Today
Mounjaro: Eli Lilly's GLP-1 Powerhouse Driving Weight Loss Revolution and Investor Interest in North - AD HOC NEWS
Eli Lilly and Company $LLY is Tema Etfs LLC's 4th Largest Position - marketbeat.com
Elser Financial Planning Boosts Stake in Eli Lilly - National Today
Elser Financial Planning Inc Has $28.18 Million Stake in Eli Lilly and Company $LLY - marketbeat.com
How Eli Lilly’s oral GLP-1 could change the obesity drug market - Healthcare Brew
Eli Lilly (LLY) Valuation Check As Foundayo Oral GLP 1 Approval Lifts Obesity Growth Story - simplywall.st
Eli Lilly’s new GLP-1 weight loss pill Foundayo receives FDA approval - inkfreenews.com
Eli Lilly (LLY) Receives FDA Approval for Foundayo Weight Management Pill - Insider Monkey
Insilico and Eli Lilly Announce a Major Collaboration - Lifespan Research Institute
Eli Lilly’s LY4060874 Phase 1 Readout: What a Quiet Pipeline Update Means for LLY Investors - TipRanks
Eli Lilly and Company stock: Foundayo approval ignites 2026 boom? - AD HOC NEWS
To celebrate its anniversary, Eli Lilly marks 150 years of everything else - PRWeek
Should You Be Adding Eli Lilly (NYSE:LLY) To Your Watchlist Today? - 富途牛牛
Novo Nordisk Weight Loss Pill Outperforms Eli Lilly Rival in New Clinical Trial Data - TIKR.com
Nisa Investment Advisors Boosts Stake in Eli Lilly - National Today
Nisa Investment Advisors LLC Raises Holdings in Eli Lilly and Company $LLY - MarketBeat
Moody Lynn & Lieberson LLC Purchases 2,657 Shares of Eli Lilly and Company $LLY - MarketBeat
Nikulski Financial Inc. Raises Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company (LLY) expands Zepbound access as pricing reforms boost long-term growth outlook - MSN
FDA approves Lilly's oral GLP-1 pill Foundayo for obesity with no food or water restrictions - Manufacturing Chemist
Eli Lilly Stock (LLY) Opinions on FDA Approval of Foundayo - Moomoo
Eli Lilly to Acquire Centessa Pharmaceuticals for $6.3 Billion - thelec.net
FDA approves Eli Lilly's new weight loss pill with no food restrictions - qz.com
Eli Lilly's Foundayo Pill Approved: Stock Gains, Launch April 6, 2026News and Statistics - IndexBox
Eli Lilly, Novo Nordisk Intensify Competition With Oral Obesity Drugs - thelec.net
Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why - Yahoo Finance Singapore
Eli Lilly and Company (NYSE:LLY) Shares Down 2%Should You Sell? - MarketBeat
Novo Nordisk: Competing In A Duopoly (TSX:NOVO:CA) - Seeking Alpha
A new weight-loss pill is here, and it could reshape the GLP-1 market - Fast Company
Stocks with rising composite ratings: Eli Lilly - MSN
LLY Stock Quote Price and Forecast - CNN
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):